Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.29%AUDUSD-1.13%GBPCHF+1.05%USDCHF+0.86%GBPCAD+0.85%GBPNZD+0.74%USDTHB+0.70%USDCAD+0.69%EURGBP-0.67%AUDJPY-0.67%GBPJPY+0.65%EURAUD+0.64%NZDUSD-0.60%AUDNZD-0.54%EURUSD-0.51%USDJPY+0.48%AUDCAD-0.47%PLNJPY+0.44%GBPTRY+0.41%NOKJPY+0.34%CHFJPY-0.34%EURCHF+0.34%GBPHKD+0.32%SGDJPY+0.32%AUDCHF-0.30%USDTRY+0.29%GBPMXN-0.28%NZDCHF+0.27%CADJPY-0.20%GBPZAR+0.18%EURCAD+0.18%CADCHF+0.17%USDCNH-0.17%EURZAR+0.17%GBPUSD+0.16%USDILS+0.16%USDZAR+0.15%USDMXN+0.15%EURSGD+0.10%GBPSGD+0.10%NZDCAD+0.10%EURNZD+0.10%NZDJPY-0.09%EURNOK+0.09%CHFSGD+0.09%CHFNOK+0.07%USDSGD+0.07%EURSEK+0.07%NZDMXN+0.07%AUDSGD+0.07%CHFSEK+0.06%AUDNOK+0.06%USDNOK+0.05%EURCNH+0.05%USDPLN-0.04%USDCOP-0.04%USDSEK+0.04%USDHKD+0.04%AUDDKK-0.03%USDDKK-0.03%EURJPY-0.03%EURHKD+0.02%EURCZK-0.01%NZDSGD+0.01%EURPLN-0.01%EURDKK0.00%XAGUSD+0.64%GAGUSD+0.64%HG1-0.38%USOIL-0.27%S1-0.21%XPTUSD-0.21%C1+0.13%XAUUSD+0.12%GAUUSD+0.12%W1+0.11%UKOIL-0.10%XNGUSD-0.08%BTCUSD-0.09%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.98%ZECUSDT+0.37%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.89%XLMUSD+2.64%BCHUSDT-0.25%UNIUSD-0.02%LTCUSD+0.07%SUIUSD+2.56%HBARUSDT+1.77%TONUSD+15.77%TAOUSDT+0.26%AAVEUSD-2.38%DOTUSDT+3.04%ICPUSDT-1.90%ONDOUSDT+0.87%WLDUSDT+10.71%ARBUSDT+0.05%JUPUSDT-0.50%ATOMUSDT+1.34%INJUSDT-2.84%STXUSDT+18.01%FETUSDT+3.00%SEIUSDT+0.33%PYTHUSDT-2.83%TIAUSDT-0.29%IMXUSDT+1.58%GRTUSDT-0.14%OPUSDT-0.24%WIFUSDT+3.46%IOTAUSDT+3.13%POLUSDT-4.53%AXSUSDT+0.93%FARTCOINUSDT+0.14%EOSUSDT+4.02%DYDXUSDT+3.64%GALAUSDT+5.20%ORDIUSDT+1.40%NOTUSDT+1.55%RONINUSDT+1.63%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.29%AUDUSD-1.13%GBPCHF+1.05%USDCHF+0.86%GBPCAD+0.85%GBPNZD+0.74%USDTHB+0.70%USDCAD+0.69%EURGBP-0.67%AUDJPY-0.67%GBPJPY+0.65%EURAUD+0.64%NZDUSD-0.60%AUDNZD-0.54%EURUSD-0.51%USDJPY+0.48%AUDCAD-0.47%PLNJPY+0.44%GBPTRY+0.41%NOKJPY+0.34%CHFJPY-0.34%EURCHF+0.34%GBPHKD+0.32%SGDJPY+0.32%AUDCHF-0.30%USDTRY+0.29%GBPMXN-0.28%NZDCHF+0.27%CADJPY-0.20%GBPZAR+0.18%EURCAD+0.18%CADCHF+0.17%USDCNH-0.17%EURZAR+0.17%GBPUSD+0.16%USDILS+0.16%USDZAR+0.15%USDMXN+0.15%EURSGD+0.10%GBPSGD+0.10%NZDCAD+0.10%EURNZD+0.10%NZDJPY-0.09%EURNOK+0.09%CHFSGD+0.09%CHFNOK+0.07%USDSGD+0.07%EURSEK+0.07%NZDMXN+0.07%AUDSGD+0.07%CHFSEK+0.06%AUDNOK+0.06%USDNOK+0.05%EURCNH+0.05%USDPLN-0.04%USDCOP-0.04%USDSEK+0.04%USDHKD+0.04%AUDDKK-0.03%USDDKK-0.03%EURJPY-0.03%EURHKD+0.02%EURCZK-0.01%NZDSGD+0.01%EURPLN-0.01%EURDKK0.00%XAGUSD+0.64%GAGUSD+0.64%HG1-0.38%USOIL-0.27%S1-0.21%XPTUSD-0.21%C1+0.13%XAUUSD+0.12%GAUUSD+0.12%W1+0.11%UKOIL-0.10%XNGUSD-0.08%BTCUSD-0.09%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.98%ZECUSDT+0.37%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.89%XLMUSD+2.64%BCHUSDT-0.25%UNIUSD-0.02%LTCUSD+0.07%SUIUSD+2.56%HBARUSDT+1.77%TONUSD+15.77%TAOUSDT+0.26%AAVEUSD-2.38%DOTUSDT+3.04%ICPUSDT-1.90%ONDOUSDT+0.87%WLDUSDT+10.71%ARBUSDT+0.05%JUPUSDT-0.50%ATOMUSDT+1.34%INJUSDT-2.84%STXUSDT+18.01%FETUSDT+3.00%SEIUSDT+0.33%PYTHUSDT-2.83%TIAUSDT-0.29%IMXUSDT+1.58%GRTUSDT-0.14%OPUSDT-0.24%WIFUSDT+3.46%IOTAUSDT+3.13%POLUSDT-4.53%AXSUSDT+0.93%FARTCOINUSDT+0.14%EOSUSDT+4.02%DYDXUSDT+3.64%GALAUSDT+5.20%ORDIUSDT+1.40%NOTUSDT+1.55%RONINUSDT+1.63%
RP

Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ • Healthcare

$95.21
-$0.49 (-0.5%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$96.25
Day Range$95.1 - $97.34
Avg. Volume (3M)668K
Market Cap$6.5B
52 Week Range
$74.5$122.2
Next EarningsIn 33 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$71.2M100%
Gross Profitminus cost of goods$62.3M87%

In plain terms: out of every $100 in revenue, Rhythm Pharmaceuticals, Inc. currently loses $69.

Fundamentals & Financials

Revenue (TTM)
$239.9M
Net Income (TTM)
-$205.3M
EPS (TTM)
-$3.11
ROA (TTM)
-46.96%
Current Ratio
3.45

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+7.6%Q1 2026-$0.73
+3.5%Q2 2026-$0.83
+9.6%Q3 2026-$0.73
Next

Nov 3

in 33 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. develops and markets therapies for rare genetic obesity disorders in the biotechnology sector and trades on the NASDAQ under RYTM. Its FY2025 revenue was $189.8 million, centered on IMCIVREE, an MC4R agonist whose active compound is setmelanotide.

Name
Rhythm Pharmaceuticals, Inc.
CEO
David Meeker
Website
www.rhythmtx.com
Industry
Healthcare
Year Founded
2008
Employees
414

Today's Snapshot

AI-generated

RYTM closed 0.5% lower at 95.22, in line with a weaker sector.

Trading Volume

Below 10d avg (755.2K)

695.7K

vs S&P 500 Today

Underperforming Market

-0.71%

Updated: September 30, 2026 at 20:23 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
RYTM shows a uniformly bearish technical profile with negative momentum and a trending bias to the downside. MACD and momentum are below neutral, RSI is subdued, and the ADX signals a persistent directional move; the price sits under short-, medium- and long-term moving averages, including the 200-day series. Volume (OBV) aligns with selling pressure and volatility is moderate, while the pivot is slightly above the current level. Technical takeaway: Strong Sell — momentum, trend strength and moving-average relationships point to sustained weakness.
All signals
  • EMA (5 indicators)$97.99 - $102.99
    Sell
  • RSI (14)33.18
    Neutral
  • Stochastic %K (14, 3, 3)14.98
    Buy
  • MACD Level (12, 26)-2.84
    Sell

Peers & Related Assets

RVMDRevolution Medicines, Inc.
$205.26+0.4%
NUVLNuvalent, Inc.
$123.960.0%
PTGXProtagonist Therapeutics, Inc.
$140.89-0.1%
RLAYRelay Therapeutics, Inc.
$18.05-1.7%
VRDNViridian Therapeutics, Inc.
$20.59+3.0%
STOKStoke Therapeutics, Inc.
$26+0.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.